Documente Academic
Documente Profesional
Documente Cultură
The Larynx:
Advanced Stage Disease
JOHN F. CAREW, MD
Additionally, the optimal treatment plan which combines chemotherapy and radiation therapy with
regards to timing (sequential vs. concomitant), radiation fractionation, chemotherapeutic agents and
adjuvants remains undefined. In this section, the
diagnosis, treatment and outcome of patients with
advanced cancer of the larynx will be presented.
ANATOMY
While the basic anatomy of the larynx already has
been described in the section on early larynx cancer,
this section will highlight the critical points relevant
to treating patients with advanced cancers of the larynx. The majority of larynx cancers are found in the
glottic region (56%) followed by the supraglottic
region (41%), while tumors of the subglottic region
are relatively infrequent (1 to 2%) (Figure 81).2,15 It
is important to realize that tumors in these different
regions of the larynx have different clinical behaviors. Supraglottic tumors, for example, have a much
higher rate of occult and bilateral metastasis than
glottic primaries.10,16 The regional lymph nodes of
the neck in patients with advanced stage supraglottic tumors and clinically negative necks must therefore be addressed in treatment planning.
The connective tissue barriers which lie between
the mucosa and cartilaginous skeleton of the larynx,
namely the conus elasticus and quadrangular membrane, are critical to the understanding of patterns of
spread and clinical behavior of advanced cancers of
the larynx (Figure 82). These membranes provide a
barrier to the spread of cancer but are often breached
Supraglottic
41%
Glottic
56%
Subglottic
3%
Figure 81.
157
involving this area can then spread into the soft tissues of the neck via the foramen in the thyrohyoid
membrane or inferiorly via the paraglottic space. In
some patients, however, a connective tissue barrier
separates the preepiglottic and paraglottic space.19
The paraglottic space is the compartment which
is bounded by the thyroid lamina laterally, the
conus elasticus medially-inferiorly and the quadrangular membrane and preepiglottic space medially-superiorly. Loose connective tissue and adipose tissue lying between thyroid lamina and the
connective tissue membranes of the larynx occupy
this space. This area is most commonly involved by
advanced glottic tumors. Once this compartment is
entered, tumors can spread relatively freely in a
superior and inferior direction, as well as outside
the confines of the larynx via the cricothyroid
membrane or the preepiglottic space. Involvement
of this space frequently results in decreased vocal
fold movement.
Cancers of the larynx can be classified as
advanced (stage III or IV) either by virtue of an
advanced primary tumor or by the presence of
regional lymph node metastasis. When regional
lymph node metastases are present they are
described by their location, number and size. The
location of the lymph nodes is described by levels in
the neck as illustrated in the chapter on neck metastasis. Levels II, III and IV are at highest risk for
lymph node metastasis from cancers in the larynx.
Figure 82. A, Sagittal section of larynx demonstrating the preepiglottic and B, coronal section of larynx
demonstrating the paraglottic space.
158
Diagnosis
Patients with advanced glottic cancers will present
with symptoms similar to patients with early glottic
cancers. As listed earlier these include hoarseness or
a change in the quality of voice, odynophagia, halitosis or otalgia. Not suprisingly the more ominous
symptoms, such as hemoptysis, dysphagia, airway
compromise and neck mass are more common in
advanced stage disease. Additionally, the supraglottic
and subglottic lesions tend to be less symptomatic
and their insidious growth results in a high percent of
patients presenting with advanced stage disease.
As mentioned earlier, adequate examination of
the larynx by use of the laryngeal mirror or a rigid
telescope or fiberoptic flexible nasopharyngoscope
is essential to staging and treatment planning (Figure 84).20 Critical in this evaluation is assessment
of the epicenter of the tumor, vocal fold mobility,
extra-laryngeal involvement and regional lymph
nodes in the neck. Although early tumors are often
adequately assessed by history and physical exam
alone, appropriate evaluation of advanced lesions
B
Figure 83. Whole organ sections showing tumor involving the
preepiglottic and paraglottic space.
159
D
Figure 84. Endoscopic view and assessment of a laryngeal cancer using the A-0; B-30; C-70; D-120 telescopes.
160
A
Figure 85. A, Axial CT of advanced laryngeal primary tumor
demonstrating paraglottic involvement and cartilage destruction but
without extension into the soft tissues of the neck. B, Axial CT of
advanced laryngeal primary tumor demonstrating cartilage destruction and extension into the soft tissues of the neck.
sis shows ominous clinical signs suggesting unresectability, then certainly a surgical option should
not be contemplated and consideration given to
chemotherapy and radiation therapy.26,27 A clinical
situation which is interesting but infrequent arises
when a patient presents with an early stage primary
lesion and clinically apparent regional lymph node
metastasis. In this situation several treatment options
exist. If the primary lesion is best treated by radia-
161
162
B
Figure 86. Schematic diagram of two well-described voice-preserving, extended laryngeal procedures: A, supracricoid laryngectomy with cricohyoidoepiglottopexy and B, supracricoid laryngectomy with cricohyoidopexy (dotted lines represent line of surgical excision).
163
The complications associated with total laryngectomy can be divided into acute and chronic. The
acute complications include those related to surgery
and general anesthesia. These include bleeding,
infection, pneumonia and fistula. The most troublesome of these is the pharyngocutaneous fistula. The
fistula rate following total laryngectomy remains
relatively high, ranging from 8 to 22 percent.3335
Appropriate treatment of a pharyngocutaneous fistula requires early recognition and then wide opening of the wound with appropriate wound care. The
patient should stop all oral intake and an alternative
route of alimentation should be established. If significant carotid exposure is seen, then consideration
should be given to coverage with a regional flap to
afford carotid protection, especially in the setting of
previous radiation therapy. Often the fistula will
close spontaneously with aggressive wound care. In
those cases where it does not, local, regional and
even free flaps may be used to obtain closure.
The most common chronic complication of total
laryngectomy is stricture formation with dysphagia. It
is crucial to rule out recurrent tumor whenever a
patient develops new dysphagia or worsening dysphagia. This is usually best evaluated by endoscopy
with direct visualization of the mucosa of the
neopharynx. Preoperative esophagrams are often
helpful in defining the location and extent of stricture.
If a stricture is seen, it can usually be dilated, although
repeated treatments are often required. Ultimately, if
a stricture is unresponsive to these conservative measures, consideration can be given to free tissue transfer to reconstruct an adequate neopharynx.
The early sequelae of radiation therapy relate primarily to the acute tissue reactions with characteristic skin changes and mucositis. These are managed
symptomatically with oral hygiene and topical medications. The late sequelae of radiation therapy
include skin changes, xerostomia and, very rarely,
chondroradionecrosis of the laryngeal skeleton.
Xerostomia is treated symptomatically with oral
hygiene and humidification. In severe cases where
chondroradionecrosis profoundly impairs swallow-
164
sisted of total laryngectomy with the resultant deleterious effects on deglutition, phonation and the creation of a permanent tracheostoma. The psychosocial
consequences of total laryngectomy have been well
studied.14,3739 Not suprisingly, quality of life measurements and psychosocial indicators are significantly affected by total laryngectomy. Although techniques for voice rehabilitation have improved, studies
have shown that the psychosocial effects of laryngectomy are as much related to loss of voice as they
are to other factors such as the necessity of a permanent tracheostoma.14,38,39 When the patients treated in
the Veterans Affairs Laryngeal Cancer Study Group
were evaluated, an improved long-term quality of life
was seen in the cohort who were randomized to
chemotherapy and radiation therapy compared to
those treated by surgery and radiation therapy.37
Interestingly, this difference was primarily related to
freedom from pain, better emotional well-being and
lower levels of depression rather than the preservation of the ability to speak.
Nevertheless, several methods are available to
rehabilitate the ability of a patient to communicate
following total laryngectomy. Many patients are able
to acquire esophageal speech, in which air is swallowed and then used to create a voice. Approximately 2 decades ago a significant advance in the
rehabilitation of patients with laryngectomies took
place when the tracheoesophageal puncture was
developed.40 This is a relatively minor procedure
where a fistula is created between the trachea and
esophagus (Figure 87). A prosthesis with a oneway valve is placed into this fistula, which allows
the creation of a lung powered voice. In the motivated patient, this voice can be quite good.
Outcomes and Results of Treatment
Historically, surgery in the form of total laryngectomy
followed by adjuvant postoperative radiation therapy
has been the standard treatment for most patients with
advanced stage cancer of the larynx.1012,41,42 Additionally, selected patients with advanced stage larynx
cancer have been treated with definitive radiation
therapy alone.13,42,43 The results of these treatments
are summarized in Table 82 with 5-year survival
ranging from 54 to 91 percent.1013,4143
Figure 87.
Author
12
Kirchner
Harwood13
Harwood43
Yuen41
Year
No.
Type of
Therapy
1977
1979
1983
1984
308
353
410
192
50
100
65
116
65
S/RT
RT
RT
S
S/RT
RT
SRT
S/RT
SRT
Mendenhall42 1992
Nguyen11
Myers10
1996
1996
165
5 yr
Stage
Survival
III/IV (%)
(%)
100
54
66
100
100
100
100
100
100
5456*
70
57
77
91
74
63
68
62
ynx preservation rates ranging from 64 to 79 percent, locoregional failure rates ranging from 20 to
33 percent and distant failure rates ranging from 8 to
21 percent.39,25 It should be noted, however, that
only one of these studies was limited only to patients
with laryngeal primaries,3 while the remainder of
the studies included patients with hypopharynx,
oropharynx, oral cavity and even paranasal sinuses
as sites of primary tumors.49,25 The majority of
these studies that included non-laryngeal sites did so
because surgical treatment of the primary would
have required total laryngectomy. The data presented
Author
Year
No.
Jacobs4
Demard5
1987
1990
30
50
C/RT
C/RT
100
64
Veterans Affairs
Larynx Group3
Pfister6
Karp7
Urba8
Clayman9
(includes data
from Shirinian)25
1991
166
166
13
14
8
26
52
C/RT
S/RT
C/RT
C/RT
C/RT
C/RT
S/RT
100
100
98
92
93
96
96
1991
1991
1994
1995
52*
74*
(Response
rate)
68
68*
77*
50*
75*
68*
81*
166
tion chemotherapy followed by conventional fraction radiation therapy. For this reason, along with the
potential for treatment related morbidity, it remains
investigational at this time.
Finally, novel treatment strategies continue to
evolve which intend to further improve the survival
and functional outcome in patients with advanced
cancer of the larynx. One such unique strategy utilizes the high-dose intra-arterial cisplatin with a systemic neutralizing agent along with conventional
radiation therapy.54 In this study, where the majority
of patients had stage IV disease (86%) and clinically
involved regional lymph nodes (79%), a major
response rate was seen in 95 percent of patients. Nine
of 10 patients retained their larynx and 2-year disease-specific survival was 76 percent. It should be
noted that 3 of the 42 patients experienced central
nervous system complications as a result of catheritization of the carotid system. Nevertheless, this
remains a promising option and a novel approach in
the treatment of advanced laryngeal cancer.
5.
6.
7.
8.
9.
10.
11.
CONCLUSION
The treatment of patients with advanced cancers of
the larynx has changed dramatically over the last 2
decades. While anatomic preservation of the larynx
can now be achieved in a large fraction of patients,
overall survival remains unchanged. The continued
optimization of multimodality treatment paradigms
along with the incorporation of biological markers,
novel treatment approaches, novel chemotherapeutic
agents and innovative biologic and gene transfer
techniques will hopefully further increase our ability
to improve survival in these patients.
12.
13.
14.
15.
16.
REFERENCES
17.
1. Hoffman HT, Karnell LH, Funk GF, et al. The National Cancer Data Base report on cancer of the head and neck. Arch
Otolaryngol Head Neck Surg 1998;124(9):95162.
2. Shah JP, Karnell LH, Hoffman HT, et al. Patterns of care for
cancer of the larynx in the United States. Arch Otolaryngol Head Neck Surg 1997;123(5):47583.
3. Induction chemotherapy plus radiation compared with
surgery plus radiation in patients with advanced laryngeal
cancer. The Department of Veterans Affairs Laryngeal
Cancer Study Group [see comments]. N Engl J Med
1991;324(24):168590.
4. Jacobs C, Goffinet DR, Goffinet L, et al. Chemotherapy as a
18.
19.
20.
21.
167
168
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
DeSanto LW, Olsen KD, Perry WC, et al. Quality of life after
surgical treatment of cancer of the larynx. Ann Otol Rhinol Laryngol 1995;104(10 Pt 1):7639.
Singer MI. Blom ED. Tracheoesophageal puncture: A surgical prosthetic method for post laryngectomy speech
restoration. Third International Symposium on Plastic
Reconstructive Surgery of the Head and Neck, 1979.
Yuen A, Medina JE, Goepfert H, Fletcher G. Management of
stage T3 and T4 glottic carcinomas. Am J Surg 1984;
148(4):46772.
Mendenhall WM, Parsons JT, Stringer SP, et al. Stage T3
squamous cell carcinoma of the glottic larynx: a comparison of laryngectomy and irradiation. Int J Radiat Oncol
Biol Phys 1992;23(4):72532.
Harwood AR, Beale FA, Cummings BJ, et al. Supraglottic
laryngeal carcinoma: an analysis of dose-time-volume
factors in 410 patients. Int J Radiat Oncol Biol Phys
1983;9(3):3119.
Wendt TG, Grabenbauer GG, Rodel CM, et al. Simultaneous
radiochemotherapy versus radiotherapy alone in
advanced head and neck cancer: a randomized multicenter study. J Clin Oncol 1998;16(4):131824.
Adelstein DJ, Saxton JP, Lavertu P, et al. A phase III randomized trial comparing concurrent chemotherapy and
radiotherapy with radiotherapy alone in resectable stage
III and IV squamous cell head and neck cancer: preliminary results. Head Neck 1997;19(7):56775.
Withers HR, Taylor JM, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy.
Acta Oncol 1988;27(2):13146.
Bourhis J, Wilson G, Wibault P, et al. Rapid tumor cell proliferation after induction chemotherapy in oropharyngeal
cancer. Laryngoscope 1994;104(4):46872.
Fowler JF, Lindstrom MJ. Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys
1992;23(2):45767.
Wang CC, Blitzer PH, Suit HD. Twice-a-day radiation therapy for cancer of the head and neck. Cancer 1985;55(9
Suppl):21004.
Eisbruch A, Thornton AF, Urba S, et al. Chemotherapy followed by accelerated fractionated radiation for larynx
preservation in patients with advanced laryngeal cancer. J
Clin Oncol 1996;14(8):232230.
Adelstein DJ, Saxton JP, Van Kirk MA, et al. Continuous
course radiation therapy and concurrent combination
chemotherapy for squamous cell head and neck cancer.
Am J Clin Oncol 1994;17(5):36973.
Glicksman AS, Wanebo HJ, Slotman G, et al. Concurrent
platinum-based chemotherapy and hyperfractionated
radiotherapy with late intensification in advanced head
and neck cancer. Int J Radiat Oncol Biol Phys
1997;39(3):7219.
Taylor SG, Murthy AK, Vannetzel JM, et al. Randomized
comparison of neoadjuvant cisplatin and fluorouracil
infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. J Clin Oncol
1994;12(2):38595.
Robbins KT, Fontanesi J, Wong FS, et al. A novel organ
preservation protocol for advanced carcinoma of the larynx and pharynx. Arch Otolaryngol Head Neck Surg
1996;122(8):8537.